$BCRX BIOCRYST PHARMACEUTICALS INC Insider Trading Week 47/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOCRYST PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOCRYST PHARMACEUTICALS INC in week 47/2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 30 2018 | BCRX | BIOCRYST PHARMACEU ... | Erck Stanley C | Director | Option Exercise | M | 1.49 | 8,333 | 12,416 | 0 | |
| Nov 30 2018 | BCRX | BIOCRYST PHARMACEU ... | Erck Stanley C | Director | Buy | M | 1.49 | 8,333 | 12,416 | 48,333 | 40 K to 48.3 K (+20.83 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 12,000 | 38,640 | 101,427 | |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.01 | 2,455 | 22,120 | 0 | 2.5 K to 0 (-100.00 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.06 | 12,000 | 108,720 | 2,455 | 14.5 K to 2.5 K (-83.02 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 12,000 | 38,640 | 14,455 | 2.5 K to 14.5 K (+488.80 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 3,500 | 13,230 | 28,305 | |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 7,000 | 26,460 | 31,805 | |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 5.45 | 5,000 | 27,250 | 12,000 | |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 9.66 | 3,500 | 33,810 | 137,383 | 140.9 K to 137.4 K (-2.48 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 3,500 | 13,230 | 140,883 | 137.4 K to 140.9 K (+2.55 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 9.08 | 7,000 | 63,560 | 137,383 | 144.4 K to 137.4 K (-4.85 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 7,000 | 26,460 | 144,383 | 137.4 K to 144.4 K (+5.10 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 9.41 | 5,000 | 47,050 | 137,383 | 142.4 K to 137.4 K (-3.51 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 5.45 | 5,000 | 27,250 | 142,383 | 137.4 K to 142.4 K (+3.64 %) |